FDA OKs Sandoz’s Biosimilar Adalimumab-adaz  Specialty Pharmacy Times

Officials with the FDA have approved Sandoz’s adalimumab-adaz (Hyrimoz), a biosimilar of Humira, according to a press release. Adalimumab-adaz is indicated …

X